Interestingly, hERG, another partner of KCNE2, is expressed in gastric cancer cells but not normal gastric epithelia, and the hERG channel blocker cisapride was previously found to suppress gastric cancer cell growth by inhibiting entry into S phase from G(1) phase in the cell cycle, increasing apoptosis [29]. This evidence concerns the gene KCNE2 and gastric cancer.